YBX1 and cancer: Taken together, these data suggest that YB-1 expression is required for the maintenance of intrinsic cellular resistance to certain anti-cancer agents, both through the transcriptional regulation of multi-drug transporter pump ABCB1 and in the case of cisplatin and JQ1, two non-ABCB1 substrates, alternative resistance mechanisms.